Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesAvricore Health Inc

Avricore Health Inc

Healthcare Diagnostics & Research
PortfolioPortfolio WatchlistWatchlist
Company price
0.05 CAD 0.00(0%)
Last update at 2026-11-03T14:30:00Z
Market Cap
6.08M

Momentum Score

…

Avricore Health Inc. engages in the health data and point-of-care technologies business. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.05
Low
0.05
High
52 Week Price Range
0.04
Low
0.10
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Avricore Health Inc is a Canadian diagnostics and digital-health company on the TSX Venture Exchange that develops point-of-care testing platforms and associated software for primary-care and remote settings. Long-term growth may be supported by rising demand for decentralized testing and the commercialization of its testing platforms and services, which could generate recurring revenue and partnership opportunities.

Key risks include execution and financing challenges typical of small-cap healthcare companies, plus regulatory approvals, reimbursement uncertainty and competition from larger diagnostics and digital-health firms.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.05
Dividend Yield
-
Revenue TTM
1.92M
Revenue Per Share
0.02
Gross Profit TTM
0.84M
Debt / Equity
-
ROE
-86.10%
Net Debt
0.70M
ROCE
7.08%
Diluted EPS TTM
-0.02

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -0.67M -0.70M -0.82M -1.71M -1.17M
Net income -0.67M -0.70M -0.82M -1.71M -1.17M
Selling general administrative 1.69M 1.84M 1.01M 1.71M 0.85M
Selling and marketing expenses - - 0.18M - 0.00M
Gross profit 1.88M 1.20M 0.46M 0.03M 0.02M
Reconciled depreciation 0.45M 0.42M 0.18M 0.02M 0.07M
Ebit - - -0.81M -1.75M -0.98M
Ebitda - - -0.63M -1.73M -0.86M
Depreciation and amortization - - 0.18M 0.02M 0.12M
Operating income 0.14M -0.69M -0.81M -1.75M -0.86M
Other operating expenses - - 2.58M 1.86M 0.89M
Interest expense - 0.00M 0.01M 0.04M 0.16M
Interest income 0.00M 0.00M 0.01M 0.00M 0.00M
Net interest income -0.01M -0.00M 0.00M -0.04M -0.16M
Income tax expense - - - 0.04M 0.04M
Total revenue 4.79M 3.49M 1.77M 0.12M 0.03M
Total operating expenses 4.65M 4.17M 1.27M 1.77M 0.87M
Cost of revenue 2.91M 2.28M 1.31M 0.09M 0.02M
Total other income expense net -0.80M -0.01M -0.01M 0.08M -0.16M
Net income from continuing ops -0.67M -0.70M -0.82M -1.71M -1.17M
Net income applicable to common shares - - - -1.71M -1.17M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 2.30M 2.54M 2.57M 2.28M 0.44M
Intangible assets 0.06M 0.05M 0.03M 0.03M 0.00M
Other current assets - - - 0.01M 0.06M
Total liab 0.33M 0.53M 0.60M 0.08M 1.15M
Total stockholder equity 1.97M 2.01M 1.96M 2.20M -0.71M
Common stock - - - 26.62M 22.29M
Capital stock 27.30M 27.19M 27.06M 26.62M 22.29M
Retained earnings -32.40M -31.74M -31.03M -30.22M -28.51M
Cash 1.13M 0.28M 0.62M 2.01M 0.30M
Total current liabilities 0.33M 0.53M 0.60M 0.08M 1.15M
Net debt - - - - 0.70M
Short long term debt - 0.04M 0.04M 0.04M 1.00M
Other stockholder equity - - - 5.79M 5.51M
Property plant equipment - - - 0.09M -
Total current assets 1.58M 0.77M 1.43M 2.16M 0.44M
Net tangible assets - - - 2.17M -0.71M
Short term investments 0.01M 0.01M 0.01M - -
Net receivables 0.41M 0.42M 0.75M 0.09M 0.01M
Inventory 0.00M 0.02M - - -
Accounts payable 0.26M 0.43M 0.26M 0.04M 0.13M
Non current assets total 0.72M 1.76M 1.14M 0.12M 0.00M
Capital lease obligations - - - - 0.00M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments 0.00M -1.05M -1.21M -0.14M -0.00M
Change to liabilities - - - -0.07M -0.34M
Total cashflows from investing activities - - - -0.14M -0.14M
Net borrowings -0.03M - - -1.00M 0.93M
Total cash from financing activities 0.06M 0.04M 0.25M 3.08M 1.51M
Change to operating activities - - - 0.07M 0.05M
Net income -0.67M -0.70M -0.82M -1.71M -1.17M
Change in cash 0.86M -0.34M -1.39M 1.71M 0.29M
Begin period cash flow 0.28M 0.62M 2.01M 0.30M 0.01M
End period cash flow 1.13M 0.28M 0.62M 2.01M 0.30M
Total cash from operating activities 1.00M 0.66M -0.44M -1.23M -1.22M
Issuance of capital stock - 0.00M 0.00M 2.40M 0.63M
Depreciation 0.45M 0.42M 0.18M 0.02M 0.01M
Change to inventory 0.02M -0.02M -0.27M 0.07M -0.18M
Change to account receivables 0.01M 0.34M -0.69M -0.08M 0.00M
Other cashflows from financing activities - - 0.25M 1.68M 0.90M
Change to netincome - - - 0.53M 0.42M
Capital expenditures 0.21M 1.05M 1.20M 0.14M 0.11M
Change in working capital -0.11M 0.23M -0.14M -0.08M -0.47M
Stock based compensation 0.54M 0.70M 0.33M 0.50M 0.13M
Other non cash items - -0.00M 0.01M 0.04M 0.29M
Free cash flow 0.80M -0.39M -1.64M -1.37M -1.22M

Peer Comparison*

Sector: Healthcare Industry: Diagnostics & Research

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
AVCR
Avricore Health Inc		 -
-%		 0.05 - - 3.16 5.09 3.30 41.13
TELO
Telo Genomics Corp		 -
-%		 0.05 - - - 8.78 - -6.32
ARC
Arian Resources Corp.		 -
-%		 0.01 - - 2.12 - 15.59 2.25
MBI-H
Med BioGene Inc		 -0.01
25.00%		 0.01 - - - - - -3.03

Profile*

Avricore Health Inc

Avricore Health Inc. engages in the health data and point-of-care technologies business. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.

789 West Pender Street, Vancouver, BC, Canada, V6C 1H2

604 773 8943

https://avricore.com

Name Title Year Born
Mr. Hector Bremner CEO & Director 1982
Ms. Kiriaki Smith CPA, CFO, CGA, CPA CFO & Corp. Sec. 1967
Mr. Rodger Seccombe Head of Healthtab Division & Director 1981
Mr. Will Seccombe Communications Advisor NA
Dr. Allan Shapiro Mang. of Bus. Devel. NA
Ms. Kiriaki Smith CPA, CFO, CGA, CPA CFO & Corporate Secretary 1967
Mr. Rodger Seccombe CTO & Director 1981
Mr. Rodger Seccombe CEO, CTO & Director 1981
Ms. Kiriaki Smith CPA, CFO, CGA CFO & Corporate Secretary 1967

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

PRL
CAD 29.99
+13.13%
AP-UN
CAD 4.19
+12.94%
ARTG
CAD 39.66
+12.93%
BZ
CAD 4.14
+10.99%
FFH
CAD 2759.48
+10.87%
DRUG
CAD 27.12
-26.86%
HUT
CAD 69.10
-22.27%
UCU
CAD 2.04
-16.39%
PHX
CAD 10.85
-14.43%
MOON
CAD 4.09
-12.79%

Equity Sectors*

  • Basic Materials

    +3.69%

  • Communication Services

    +2.61%

  • Consumer Cyclical

    +2.96%

  • Consumer Defensive

    +1.11%

  • Energy

    -5.01%

  • Financial Services

    +2.20%

  • Healthcare

    -0.56%

  • Industrials

    -0.73%

  • Real Estate

    +1.90%

  • Technology

    +0.05%

  • Utilities

    +1.39%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…